Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Endoscopy Division, Chiba Cancer Center, Chiba, Japan.
Gastrointest Endosc. 2021 Mar;93(3):647-653. doi: 10.1016/j.gie.2020.07.053. Epub 2020 Jul 29.
Endoscopic treatment is recommended for low-grade dysplasia (LGD), high-grade dysplasia (HGD), and colorectal cancer (CRC) with submucosal (SM) invasion <1000 μm. However, diagnosis of invasion depth requires experience and is often difficult. This study developed and evaluated a novel computer-aided diagnosis (CAD) system to determine whether endoscopic treatment is appropriate for colorectal lesions using only white-light endoscopy (WLE).
We extracted 3442 images from 1035 consecutive colorectal lesions (105 LGDs, 377 HGDs, 107 CRCs with SM <1000 μm, 146 CRCs with SM ≥1000 μm, and 300 advanced CRCs). All images were WLE, nonmagnified, and nonstained. We developed a novel CAD system using 2751 images; the remaining 691 images were evaluated by the CAD system as a test set. The capability of the CAD system to distinguish endoscopically treatable lesions and untreatable lesions was assessed and compared with the results from 2 trainees and 2 experts.
The CAD system distinguished endoscopically treatable from untreatable lesions with 96.7% sensitivity, 75.0% specificity, and 90.3% accuracy. These values were significantly higher than those from trainees (92.1%, 67.6%, and 84.9%; P < .01, <.01, and <.01, respectively) and were comparable with those from experts (96.5%, 72.5%, and 89.4%, respectively). Trainees assisted by the CAD system demonstrated a diagnostic capability comparable with that of experts.
The CAD system had good diagnostic capability for making treatment decisions for colorectal lesions. This system may enable a more convenient and accurate diagnosis using only WLE.
对于低级别异型增生(LGD)、高级别异型增生(HGD)和黏膜下(SM)侵犯<1000μm 的结直肠癌(CRC),建议进行内镜治疗。然而,对于浸润深度的诊断需要经验,并且常常很困难。本研究开发并评估了一种新的计算机辅助诊断(CAD)系统,该系统仅使用白光内镜(WLE)来确定结直肠病变是否适合进行内镜治疗。
我们从 1035 例连续的结直肠病变(105 例 LGD、377 例 HGD、107 例 SM<1000μm 的 CRC、146 例 SM≥1000μm 的 CRC 和 300 例进展期 CRC)中提取了 3442 张图像。所有图像均为 WLE、非放大、非染色。我们使用 2751 张图像开发了一种新的 CAD 系统;其余 691 张图像作为测试集由 CAD 系统进行评估。评估了 CAD 系统区分可内镜治疗病变和不可治疗病变的能力,并与 2 名受训者和 2 名专家的结果进行了比较。
CAD 系统区分可内镜治疗和不可治疗病变的敏感性、特异性和准确性分别为 96.7%、75.0%和 90.3%。这些值明显高于受训者(92.1%、67.6%和 84.9%;P<.01、<.01 和<.01,分别),与专家相当(96.5%、72.5%和 89.4%,分别)。接受 CAD 系统辅助的受训者表现出与专家相当的诊断能力。
CAD 系统对结直肠病变的治疗决策具有良好的诊断能力。该系统仅使用 WLE 即可实现更方便、更准确的诊断。